naltrexone implant

DRUG5 trials

Sponsors

University of Pennsylvania, Go Medical Industries Pty Ltd, Shenzhen Sciencare Medical Industries Co., Ltd.

Conditions

AUDHIVHIV InfectionsHeroin DependenceOpioid Use DisorderOpioid-Related DisordersSubstance Abuse

Phase 1

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

CompletedNCT03810495

Go Medical Industries Pty LtdOpioid Use Disorder

Start: 2019-04-11End: 2021-03-22Updated: 2024-11-12

Exploring the PK of Different Doses of Naltrexone in Patients With AUD

Shenzhen Sciencare Medical Industries Co., Ltd.AUD

Start: 2023-06-16End: 2024-05-01Target: 60Updated: 2023-06-26

Phase 2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

CompletedNCT00218426

University of PennsylvaniaHeroin Dependence, Opioid-Related Disorders

Start: 2006-07-31End: 2010-11-04Updated: 2019-03-18

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

CompletedNCT01101815

University of PennsylvaniaHIV, HIV Infections, Substance Abuse

Start: 2010-06-30End: 2016-12-31Updated: 2018-11-08

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

Not yet recruitingNCT05382091

Go Medical Industries Pty LtdOpioid Use Disorder

Start: 2026-07-15End: 2029-07-15Target: 250Updated: 2026-02-23

Related Papers

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

2019-03-1414 citations